Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc.（MLYS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mlys · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$56.00
Consensus
$46.00
+101.8% upside
Low
$30.00
Median: $52 · Last Close: $22.80
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$46.00
101.8% upside
High Target
$56
145.6%
Low Target
$30
31.6%
Current Price
$22.80
as of today
Based on analyst price targets, the MLYS stock price prediction for the next 12 months ranges from $30 to $56. The consensus MLYS price forecast of $46.00 implies 101.8% upside from the current price of $22.80.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $21.66 | ↓ 5.00% |
1-day model range: $21.47–$21.85. Peak: $21.85 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MLYS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-13 | B of A Securities | Maintains | Buy→Buy |
| 2025-12-19 | Stifel | Maintains | Buy→Buy |
| 2025-11-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-11 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-11 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-09-09 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-09-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-03 | Jefferies | Maintains | Hold→Hold |
| 2025-08-28 | B of A Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Mineralys Therapeutics, Inc. (MLYS) stock. Of the recent 24 rating actions, 0 were upgrades and 0 were downgrades. 8 analysts currently cover MLYS.
分析师推荐趋势
MLYS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 99.8% YoY
Revenue Next Year
$121M
↑ 21687.0% YoY
EPS This Year
$-2.31
EPS Next Year
$-2.10
↓ 9.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast MLYS EPS of $-2.31 for the current fiscal year, based on estimates from 6 analysts. The MLYS revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MLYS 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MLYS 的共识目标价为 $46.00（+101.8% 上行空间），分析师共识为 Buy。
MLYS 的短期预测（明日）为 $21.66（-5.00%）。
Mineralys Therapeutics, Inc. 在 NASDAQ 上市，代码 MLYS。MLYS 在 2027 年的整体展望偏积极，在覆盖分析师中约 88% 对应 Buy 共识。
常见问题
MLYS 预测 · 8 个问题根据 8 位华尔街分析师，MLYS 的 12 个月平均目标价为 $46.00，最高 $56.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $22.80，隐含约 +101.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.